Cargando…
Late presentation of cancer in compound heterozygote PMS2 mutation carrier
Autores principales: | van Galen, Paulien P, Perrier, Renee, Bernier, Francois P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288898/ http://dx.doi.org/10.1186/1897-4287-9-S1-P38 |
Ejemplares similares
-
An unusual tumor spectrum in Lynch syndrome caused by MSH6 mutation
por: Perrier, Renee L, et al.
Publicado: (2010) -
Cancer susceptibility in ATM heterozygotes: do two distinct carrier populations exist?
por: Gatti, RA, et al.
Publicado: (2000) -
FMF in heterozygotes: are we able to accurately diagnose the disease in very young children?
por: Hentgen, Véronique, et al.
Publicado: (2011) -
Reply: ‘Behr syndrome’ with OPA1 compound heterozygote mutations
por: Yu-Wai-Man, Patrick, et al.
Publicado: (2015) -
Cellular responses to ionising radiation of AT heterozygotes: differences between missense and truncating mutation carriers
por: Fernet, M, et al.
Publicado: (2004)